Literature DB >> 33504876

The effects of bone marrow stem and progenitor cell seeding on urinary bladder tissue regeneration.

Matthew I Bury1, Natalie J Fuller1, Renea M Sturm1, Rebecca R Rabizadeh1, Bonnie G Nolan1, Milica Barac1, Sonia S Edassery1, Yvonne Y Chan1, Arun K Sharma2,3,4,5,6,7.   

Abstract

Complications associated with urinary bladder augmentation provide the motivation to delineate alternative bladder tissue regenerative engineering strategies. We describe the results of varying the proportion of bone marrow (BM) mesenchymal stem cells (MSCs) to CD34 + hematopoietic stem/progenitor cells (HSPCs) co-seeded onto synthetic POC [poly(1,8 octamethylene citrate)] or small intestinal submucosa (SIS) scaffolds and their contribution to bladder tissue regeneration. Human BM MSCs and CD34 + HSPCs were co-seeded onto POC or SIS scaffolds at cell ratios of 50 K CD34 + HSPCs/15 K MSCs (CD34-50/MSC15); 50 K CD34 + HSPCs/30 K MSCs (CD34-50/MSC30); 100 K CD34 + HSPCs/15 K MSCs (CD34-100/MSC15); and 100 K CD34 + HSPCs/30 K MSCs (CD34-100/MSC30), in male (M/POC; M/SIS; n = 6/cell seeded scaffold) and female (F/POC; F/SIS; n = 6/cell seeded scaffold) nude rats (n = 96 total animals). Explanted scaffold/composite augmented bladder tissue underwent quantitative morphometrics following histological staining taking into account the presence (S+) or absence (S-) of bladder stones. Urodynamic studies were also performed. Regarding regenerated tissue vascularization, an upward shift was detected for some higher seeded density groups including the CD34-100/MSC30 groups [F/POC S- CD34-100/MSC30 230.5 ± 12.4; F/POC S+ CD34-100/MSC30 245.6 ± 23.4; F/SIS S+ CD34-100/MSC30 278.1; F/SIS S- CD34-100/MSC30 187.4 ± 8.1; (vessels/mm2)]. Similarly, a potential trend toward increased levels of percent muscle (≥ 45% muscle) with higher seeding densities was observed for F/POC S- [CD34-50/MSC30 48.8 ± 2.2; CD34-100/MSC15 53.9 ± 2.8; CD34-100/MSC30 50.7 ± 1.7] and for F/SIS S- [CD34-100/MSC15 47.1 ± 1.6; CD34-100/MSC30 51.2 ± 2.3]. As a potential trend, higher MSC/CD34 + HSPCs cell seeding densities generally tended to increase levels of tissue vascularization and aided with bladder muscle growth. Data suggest that increasing cell seeding density has the potential to enhance bladder tissue regeneration in our model.

Entities:  

Year:  2021        PMID: 33504876      PMCID: PMC7840904          DOI: 10.1038/s41598-021-81939-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

1.  The decompensated detrusor I: the effects of bladder outlet obstruction on the use of intracellular calcium stores.

Authors:  D Rohrmann; R M Levin; J W Duckett; S A Zderic
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

2.  Long-Term Surgical Management of Severe Pelvic Injury and Resulting Neurogenic Bladder From an Improvised Explosive Device.

Authors:  Darshan P Patel; Andrew W Southwick; William O Brant; James M Hotaling; William Peche; Jeremy B Myers
Journal:  Fed Pract       Date:  2016-01

3.  Complications after use of gastric segments for lower urinary tract reconstruction.

Authors:  Miguel Castellan; Rafael Gosalbez; Yuval Bar-Yosef; Andrew Labbie
Journal:  J Urol       Date:  2012-03-16       Impact factor: 7.450

Review 4.  Pathophysiology of interstitial cystitis.

Authors:  Lori A Birder
Journal:  Int J Urol       Date:  2019-06       Impact factor: 3.369

5.  The incidence, spectrum and outcomes of traumatic bladder injuries within the Pietermaritzburg Metropolitan Trauma Service.

Authors:  R J Urry; D L Clarke; J L Bruce; G L Laing
Journal:  Injury       Date:  2016-01-25       Impact factor: 2.586

6.  Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer.

Authors:  Makito Miyake; Takuya Owari; Mitsuru Tomizawa; Masaru Matsui; Naoko Nishibayashi; Kota Iida; Kenta Onishi; Shunta Hori; Yosuke Morizawa; Daisuke Gotoh; Yoshitaka Itami; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Urol J       Date:  2019-05-05       Impact factor: 1.510

7.  The natural history of untreated muscle-invasive bladder cancer.

Authors:  Alberto Martini; John P Sfakianos; Lotta Renström-Koskela; Ashkan Mortezavi; Ugo G Falagario; Lars Egevad; Abolfazal Hosseini; Reza Mehrazin; Matthew D Galsky; Gunnar Steineck; N Peter Wiklund
Journal:  BJU Int       Date:  2019-08-07       Impact factor: 5.588

8.  Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.

Authors:  Trevor M Soergel; Mark P Cain; Rosalia Misseri; Thomas A Gardner; Michael O Koch; Richard C Rink
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

Review 9.  Pelvic fracture-related urethral and bladder injury.

Authors:  Jordan J Durrant; A Ramasamy; M S Salmon; N Watkin; I Sargeant
Journal:  J R Army Med Corps       Date:  2013-03       Impact factor: 1.285

Review 10.  Military genitourinary injuries: past, present, and future.

Authors:  Felicia L Balzano; Steven J Hudak
Journal:  Transl Androl Urol       Date:  2018-08
View more
  3 in total

Review 1.  Sources, Characteristics, and Therapeutic Applications of Mesenchymal Cells in Tissue Engineering.

Authors:  Rosa Angelica Gonzalez-Vilchis; Angelica Piedra-Ramirez; Carlos Cesar Patiño-Morales; Concepcion Sanchez-Gomez; Nohra E Beltran-Vargas
Journal:  Tissue Eng Regen Med       Date:  2022-01-29       Impact factor: 4.169

Review 2.  The Role of MSCs and Cell Fusion in Tissue Regeneration.

Authors:  Jessica Dörnen; Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

Review 3.  Decellularization in Tissue Engineering and Regenerative Medicine: Evaluation, Modification, and Application Methods.

Authors:  Afarin Neishabouri; Alireza Soltani Khaboushan; Faezeh Daghigh; Abdol-Mohammad Kajbafzadeh; Masoumeh Majidi Zolbin
Journal:  Front Bioeng Biotechnol       Date:  2022-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.